In a study from Massachusetts General Hospital (MA, USA), researchers have performed a meta-analysis and study identified 17 independent SNPs from 15 genomic regions that were associated with a diagnosis of depression.
Results from COBRA, one of the largest multicenter studies of psychological treatments for depression, have indicated that inexpensive behavioral activation therapy may be as effective as cognitive behavioral therapy.
In a collaborative study researchers have found that individuals suffering from social disorders such as schizophrenia or social phobia could benefit from humanoid robotics and computer avatar aided rehabilitation.
Results of a 5 year, randomized clinical trial integrating both motivational interviewing and cognitive behavioral therapy suggests better long-term patient improvement rates for those suffering from generalized anxiety disorder.
A link between noradrenergic neurons and depression may provide new avenues for neuropsychiatric treatments for depression.
A new study reveals how brain scans could be used to identify children that are at high risk of suffering from depression in later life, information that could prove important in early intervention and prevention.
Regulation of pro-inflammatory cytokines interleukin-12 and interferon gamma observed in new study.
New research indicates that high-inflammation depression is distinct and may be targeted through drugs for increasing dopamine levels.
New research has shown that ADHD children and their mothers are more likely to have shorter telomeres, potentially increasing their risk of diseases and disorders such as cancer, diabetes and obesity.